Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

260 trials with published results (23%)

Research Maturity

766 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.5%

86 terminated out of 1141 trials

Success Rate

89.9%

+3.4% vs benchmark

Late-Stage Pipeline

28%

317 trials in Phase 3/4

Results Transparency

34%

260 of 766 completed with results

Key Signals

260 with results90% success86 terminated

Data Visualizations

Phase Distribution

896Total
Not Applicable (436)
Early P 1 (5)
P 1 (54)
P 2 (84)
P 3 (150)
P 4 (167)

Trial Status

Completed766
Unknown120
Recruiting91
Terminated86
Withdrawn30
Active Not Recruiting21

Trial Success Rate

89.9%

Benchmark: 86.5%

Based on 766 completed trials

Clinical Trials (1141)

Showing 20 of 20 trials
NCT07534475Not ApplicableNot Yet Recruiting

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT

NCT07105111Phase 4Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

NCT06373016Not ApplicableRecruitingPrimary

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

NCT06898879Not ApplicableNot Yet Recruiting

Enhancing Veteran-Clinical Collaboration in VA PRRCs

NCT05317481Not ApplicableCompletedPrimary

Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms

NCT00024635Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

NCT07140913Phase 3Recruiting

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

NCT07172516Phase 3RecruitingPrimary

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

NCT07503275Not ApplicableNot Yet RecruitingPrimary

Functional Magnetic Resonance Imaging Study of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder

NCT00001174Active Not RecruitingPrimary

Evaluation of the Genetics of Bipolar Disorder

NCT05457465Phase 2RecruitingPrimary

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

NCT05724953Phase 1Terminated

Alexithymia Intervention for Suicide

NCT05699525Not ApplicableRecruiting

Personalized Mobile Cognitive Behavioral Therapy Application

NCT03484494Not ApplicableActive Not RecruitingPrimary

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

NCT07286175Phase 2RecruitingPrimary

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

NCT03217110Not ApplicableRecruiting

Cerebellar Stimulation and Cognitive Control

NCT07479758Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

NCT06370988Not ApplicableRecruiting

Theta-Burst Stimulation for Bipolar Depression

NCT04298450Not ApplicableCompleted

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

NCT05172271Not ApplicableActive Not Recruiting

Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)

Scroll to load more

Research Network

Activity Timeline